BiotechPark with Innovation- and Incubationscenter

Berlin-Buch, with its long tradition of excellent biomedical basic and clinical research as well as clinical expertise, is an ideal environment for life science companies. The campus atmosphere is conducive to scientific exchange, technology transfer and collaborative projects.
With an area of approximately 45,000 m², the BiotechPark Berlin-Buch is one of the largest biotech parks in Germany. Here entrepreneurs and companies find affordable, industry-specific laboratory and office space with state-of-the-art facilities. Start-ups can grow and thrive in the Innovation and Incubation Center, building areas on the Campus allow for future development. The managing company, Campus Berlin-Buch GmbH, supports the companies in all matters and provides comprehensive service.
Currently, 75 companies are located on campus and employ around 850 people. More than fifty of these companies are in the biotech sector, several others offer services for the life science industry. Since 1998 the number of employees of the biotech companies has more than doubled.
The business fields of the companies range from medical technology products, molecular biological diagnostics and treatments, preclinical pharmacological and pharmacogenomic tests, RNA technologies, the search for pharma-relevant target molecules, production and testing of drugs and the analysis and synthesis of biomolecules.
From 2023 the new BerlinBioCube start-up center in BiotechPark Berlin-Buch will offer an additional 8,000 square meters of laboratory and office space and attractive services for start-ups in the fields of biotechnology and medical technology as well as adjacent areas.
„Made in Buch“ stands for high quality and innovation in the life sciences. Selected products can be found here.

News innovation
Max Delbrück Center to host Helmholtz Drug Discovery meeting
Top scientists and companies will meet in Berlin-Buch for the 2025 Helmholtz Drug Discovery Conference from April 28-30 to discuss RNA drugs, PROTACs, AI in drug discovery, and chemoproteomics and to ...
more ...Eckert & Ziegler Signs Contract Manufacturing Agreement for Yttrium-90-based PentixaTher with Pentixapharm
Eckert & Ziegler Radiopharma GmbH (EZR), a 100% subsidiary of Eckert & Ziegler SE, today announced the signing of a manufacturing agreement with Pentixapharm, a clinical-stage biopharmaceutical compan...
more ...Talk im Cube: "International Cooperation and Funding programs in Life Sciences"
On May 15, we will feature four esteemed experts in the field who will share their insights and experiences on the importance of collaboration across borders and the role of funding in advancing life ...
more ...Events Campus
06.05.2025, 19:30
Heißer Sand und Eis am Stiel - Wie unser Gehirn Temperatur erkennt
Einen Gegenstand zu berühren und sofort zu erkennen, ob er warm oder kalt ist erscheint uns natürlich. Aber wie funktioniert das eigentlich? Wo und wie verarbeitet das Gehirn die Temperaturinformation...
more ...07.05.2025, 16:00
Labor trifft Lehrer: "Retinale Bildgebung: Das Auge als Fenster zum Gehirn"
mit Dr. Frederike Oertel
more ...15.05.2025, 17:00
Talk im Cube: "International Cooperation and Funding programs in Life Sciences"
This event will feature four esteemed experts in the field who will share their insights and experiences on the importance of collaboration across borders and the role of funding in advancing life sc...
more ...